These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 19260125)

  • 1. Pulmonary hypertension does not affect the autonomic nervous system dysfunction of sickle cell disease.
    Inamo J; Connes P; Barthélémy JC; Dan V; Coates T; Loko G
    Am J Hematol; 2009 May; 84(5):311-2. PubMed ID: 19260125
    [No Abstract]   [Full Text] [Related]  

  • 2. Lung function tests in sickle cell patients.
    Bloom CI; Murphy K; Cummin AR
    Am J Hematol; 2009 May; 84(5):310; author relpy 310-1. PubMed ID: 19260123
    [No Abstract]   [Full Text] [Related]  

  • 3. Pulmonary complications of sickle cell disease.
    Gladwin MT; Vichinsky E
    N Engl J Med; 2008 Nov; 359(21):2254-65. PubMed ID: 19020327
    [No Abstract]   [Full Text] [Related]  

  • 4. Pulmonary hypertension of sickle cell disease: more than just another lung disease.
    Klings ES
    Am J Hematol; 2008 Jan; 83(1):4-5. PubMed ID: 17924550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease.
    Klings ES; Farber HW
    N Engl J Med; 2004 Jun; 350(24):2521-2; author reply 2521-2. PubMed ID: 15190149
    [No Abstract]   [Full Text] [Related]  

  • 6. The outcomes of sickle cell disease in adulthood are clear, but the origins and progression of sickle cell anemia-induced problems in the heart and lung in childhood are not.
    Boyd JH; Strunk RC; Morgan WJ
    J Pediatr; 2006 Jul; 149(1):3-4. PubMed ID: 16860112
    [No Abstract]   [Full Text] [Related]  

  • 7. Sickle cell disease-associated pulmonary hypertension: a coat of many colors.
    McLaughlin VV; Channick R
    Am J Respir Crit Care Med; 2007 Jun; 175(12):1218-9. PubMed ID: 17545455
    [No Abstract]   [Full Text] [Related]  

  • 8. Pulmonary hypertension in sickle cell disease: mechanisms, diagnosis, and management.
    Castro O; Gladwin MT
    Hematol Oncol Clin North Am; 2005 Oct; 19(5):881-96, vii. PubMed ID: 16214649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary complications of sickle cell disease in adults.
    Ardiles T; Dark D
    Mo Med; 2007; 104(3):250-4. PubMed ID: 17619501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary hypertension in sickle cell disease.
    Vichinsky EP
    N Engl J Med; 2004 Feb; 350(9):857-9. PubMed ID: 14985481
    [No Abstract]   [Full Text] [Related]  

  • 11. Pathophysiology of the pulmonary circulation.
    Barer G
    Physiol Bohemoslov; 1989; 38(1):1-12. PubMed ID: 2524074
    [No Abstract]   [Full Text] [Related]  

  • 12. Rationale for IL-1beta targeted therapy for ischemia-reperfusion induced pulmonary and other complications in sickle cell disease.
    Wanderer AA
    J Pediatr Hematol Oncol; 2009 Aug; 31(8):537-8. PubMed ID: 19636265
    [No Abstract]   [Full Text] [Related]  

  • 13. Reconstructing sickle cell disease: a data-based analysis of the "hyperhemolysis paradigm" for pulmonary hypertension from the perspective of evidence-based medicine.
    Hebbel RP
    Am J Hematol; 2011 Feb; 86(2):123-54. PubMed ID: 21264896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary complications of sickle cell disease in children.
    Caboot JB; Allen JL
    Curr Opin Pediatr; 2008 Jun; 20(3):279-87. PubMed ID: 18475096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in clinical research in sickle cell disease.
    Hagar W; Vichinsky E
    Br J Haematol; 2008 May; 141(3):346-56. PubMed ID: 18341629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sickle cell anemia pathophysiology: back to the data.
    Eckman JR; Embury SH
    Am J Hematol; 2011 Feb; 86(2):121-2. PubMed ID: 21264895
    [No Abstract]   [Full Text] [Related]  

  • 17. Pulmonary hypertension in sickle cell disease.
    Lee MT; Rosenzweig EB; Cairo MS
    Clin Adv Hematol Oncol; 2007 Aug; 5(8):645-53, 585. PubMed ID: 17982405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pulmonary arterial hypertension and sickle cell disease].
    Savale L; Maitre B; Bachir D; Galactéros F; Simonneau G; Parent F
    Presse Med; 2013 Mar; 42(3):338-46. PubMed ID: 22743045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tricuspid regurgitant jet velocity is associated with hemolysis in children and young adults with sickle cell disease evaluated for pulmonary hypertension.
    Liem RI; Young LT; Thompson AA
    Haematologica; 2007 Nov; 92(11):1549-52. PubMed ID: 18024403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease.
    Hassoun PM; Krishnan JA
    N Engl J Med; 2004 Jun; 350(24):2521-2; author reply 2521-2. PubMed ID: 15195345
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.